POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare blood cancer
Disease control CompletedThis study tested an experimental pill called bomedemstat in 20 adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal was to see if the drug is safe and can lower red blood cell levels without needing additional procedures. Participants…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
Drug dasatinib shows promise for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control these diseases and to check its safety. Results focused on how many pa…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses chemotherapy and radiation before donor stem cells are given, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer a…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for myelofibrosis patients after failed standard therapies?
Disease control CompletedThis study tested a drug called itacitinib in 4 people with a type of bone marrow cancer called myelofibrosis. All participants had already tried other treatments (ruxolitinib or fedratinib) without success. The main goals were to check safety and see if the drug could shrink an …
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for 62 people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor immune cells followed by a stem cell transplant. The goa…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC